US4651739A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Light-induced killing of carcinoma cells
Assignee: General Hospital Corp
•
Filing: 1985-04-08
•
Granted: 1987-03-24
•
Expires: 2005-04-08
Abstract
Abstract A method of killing carcinoma cells associated normal cells using light of a predetermined wavelength. The method includes contacting the cells with a chromophor at a given concentration. The chromophor is positively charged and sufficiently lipophilic to be taken up by the mitochondria of the carcinoma cells and is retained substantially longer in the mitochondria of carcinoma cells than in normal cell mitochondria; or it may be taken up in greater quantity by the carcinoma cells than by the normal cells. The chromophor must also have a therapeutic index for light-induced cell killing of at least 500 for light of the predetermined wavelength, and has a therapeutic ratio for light-induced killing of at least 50 for light of said pre-determined wavelength. The cells are then exposed to light of this wavelength.
Inventors
- 👤 Allan Oseroff
- 👤 James Foley
- 👤 Louis Cincotta
- 👤 John A. Parrish
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 07:02
CPC Classifications
A; A61; A61N; A61N5/00; A61N5/06; A61N5/0613; A61N5/062; A61K; A61K41/00; A61K41/0057; A61N5/0601; A61P; A61P35/00; A61P43/00
Claims Analysis
Total Claims: 6
Claim 1
Independent Claim
142 words
A method of killing carcinoma cells associated with normal cells using light of predetermined wavelength, said method comprising (a) contacting said cells with a chromophore at a predetermined concentration, said chromophore being characterized in that it is positively charged and sufficiently lipophilic to be taken up by said carcinoma cells and their mitochondria, it is retained substantially longer in the mitochondria of said carcinoma cells than in the mitochondria of said normal cells, or more of said chromophore is taken up by said carcinoma cells than by said normal cells contacted with said chromophore, it has a therapeutic index for light-induced cell killing of at least 500 for light of said predetermined wavelength; and it has a therapeutic ratio for light-induced killing of at least 50 for light of said pre-determined wavelength; and (b) exposing said contacted carcinoma cells to said light.
Claim 2
Independent Claim
142 words
A method of killing carcinoma cells associated with normal cells using light of predetermined wavelength, said method comprising (a) contacting said cells with a chromophore at a predetermined concentration, said chromophore being characterized in that it is positively charged and sufficiently lipophilic to be taken up by said carcinoma cells and their mitochondria, it is retained substantially longer in the mitochondria of said carcinoma cells than in the mitochondria of said normal cells, or more of said chromophore is taken up by said carcinoma cells than by said normal cells contacted with said chromophore, it has a therapeutic index for light-induced cell killing of at least 500 for light of said predetermined wavelength; and it has a therapeutic ratio for light-induced killing of at least 50 for light of said pre-determined wavelength; and (b) exposing said contacted carcinoma cells to said light.
Claim 3
Dependent Claim
107 words
The method of claim 1 wherein said chromophore is taken up by said normal cells and said carcinoma cells, and there is a time interval between steps (a) and (b) which is sufficiently long to permit dissipation from said normal cells of a sufficient amount of said chromophore to prevent killing of at least 80% of said normal cells when said cells are exposed to said light, and sufficiently short to ensure that enough of said chromophore is retained by said mitochondria of said carcinoma cells to cause at least 80% of said carcinoma cells contacted with said chromophore to be killed when exposed to said light.
Claim 4
Dependent Claim
36 words
The method of claim 1 wherein exposure of said chromophore to said light causes said chromophore in said carcinoma cell mitochondria to participate in a chemical reaction yielding a reaction product more cytotoxic than said chromophore.
Claim 5
Dependent Claim
20 words
The method of claim 1 wherein exposure of said chromophore to said light causes thermal destruction of said carcinoma cells.
Claim 6
Dependent Claim
22 words
The method of claim 1 wherein said chromophore strongly absorbs said light at said predetermined wavelength, said wavelength being above 600 nm.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1990-03-23 | 1990-09-22 | 1991-03-24 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1994-03-23 | 1994-09-22 | 1995-03-24 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1998-03-23 | 1998-09-22 | 1999-03-24 | $7700.00 | Window Closed / Lapsed |